H2 Equity has reached an agreement to buy the ophthalmology group Optegra from Eight Roads Ventures. The deal is expected to be completed early 2021.

Optegra runs 23 eye hospitals and clinics in the U.K., Poland and the Czech Republic and offers a wide-range of services including laser eye and lens replacement surgery as well as cataract treatment.

H2 plans to work with the existing management to deliver an “ambitious growth strategy.” The company’s chief executive is Peter Byloos, who joined Optegra in 2017.